New Advances in Pharmacologic and Non-pharmacologic Therapy in Heart Failure and Heart Transplant
In light of the continuous development of new pharmacological agents and device-based therapies, we made the decision to bring together the most innovative clinical studies and the most practical reviews as a part of this Special Issue to offer readers new evidence useful for the management of both...
Tallennettuna:
| Aineistotyyppi: | Online |
|---|---|
| Kieli: | englanti |
| Julkaistu: |
MDPI - Multidisciplinary Digital Publishing Institute
2024
|
| Aiheet: | |
| Linkit: | ONIX_20240704_9783725810192_88 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|
| _version_ | 1869524478743019520 |
|---|---|
| collection | Directory of Open Access Books |
| description | In light of the continuous development of new pharmacological agents and device-based therapies, we made the decision to bring together the most innovative clinical studies and the most practical reviews as a part of this Special Issue to offer readers new evidence useful for the management of both patients with heart failure and heart transplant patients. |
| format | Online |
| id | doab-20.500.12854ir-139292 |
| institution | Directory of Open Access Books |
| language | eng |
| publishDate | 2024 |
| publishDateRange | 2024 |
| publishDateSort | 2024 |
| publisher | MDPI - Multidisciplinary Digital Publishing Institute |
| publisherStr | MDPI - Multidisciplinary Digital Publishing Institute |
| record_format | ojs |
| spelling | doab-20.500.12854ir-1392922024-07-04T09:37:47Z New Advances in Pharmacologic and Non-pharmacologic Therapy in Heart Failure and Heart Transplant Masarone, Daniele Lombardi, Carlo heart failure ejection fraction network meta-analysis SGLT2-inhibitors vericiguat omecamtiv mecarbil HFpEF greater splanchnic nerve ablation chronic kidney disease estimated glomerular filtration rate sodium glucose linked transporters 2 inhibitors treatment angiotensin receptor blocker neprilysin inhibitors heart failure with reduced ejection fraction cardiorenal syndrome angiotensin receptor–neprilysin inhibitors reverse cardiac remodeling renal resistance index levosimendan disease modifier drugs advanced heart failure heart failure reduced ejection fraction autonomic dysregulation respiratory disturbances novel devices cardiac contractility modulation global longitudinal strain myocardial mechano-energetics efficiency dapsone transplant G6PD anemia inodilators pharmacologic therapy optimizer smart tricuspid regurgitation acute heart failure calcium inotropic agents istaroxime lusitropic agents Na+/K+-ATPase NKA PST2744 SERCA2a biomarkers cardiac ultrasound computer tomography therapeutic interventions preventive strategies amyloidosis heart transplant ABO subtype rejection cardiogenic shock cardiac transplantation mechanical circulatory support mitral regurgitation atrial functional mitral regurgitation atrial functional tricuspid regurgitation transcatheter tricuspid valve intervention atrial fibrillation bleeding direct oral anticoagulant heart transplantation oral anticoagulant stroke vitamin K antagonist n/a thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine In light of the continuous development of new pharmacological agents and device-based therapies, we made the decision to bring together the most innovative clinical studies and the most practical reviews as a part of this Special Issue to offer readers new evidence useful for the management of both patients with heart failure and heart transplant patients. 2024-07-04T09:37:44Z 2024-07-04T09:37:44Z 2024 book ONIX_20240704_9783725810192_88 9783725810192 9783725810208 https://directory.doabooks.org/handle/20.500.12854/139292 eng application/octet-stream Attribution-NonCommercial-NoDerivatives 4.0 International https://mdpi.com/books/pdfview/book/9288 https://mdpi.com/books/pdfview/book/9288 MDPI - Multidisciplinary Digital Publishing Institute 10.3390/books978-3-7258-1020-8 10.3390/books978-3-7258-1020-8 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 9783725810192 9783725810208 214 open access |
| spellingShingle | heart failure ejection fraction network meta-analysis SGLT2-inhibitors vericiguat omecamtiv mecarbil HFpEF greater splanchnic nerve ablation chronic kidney disease estimated glomerular filtration rate sodium glucose linked transporters 2 inhibitors treatment angiotensin receptor blocker neprilysin inhibitors heart failure with reduced ejection fraction cardiorenal syndrome angiotensin receptor–neprilysin inhibitors reverse cardiac remodeling renal resistance index levosimendan disease modifier drugs advanced heart failure heart failure reduced ejection fraction autonomic dysregulation respiratory disturbances novel devices cardiac contractility modulation global longitudinal strain myocardial mechano-energetics efficiency dapsone transplant G6PD anemia inodilators pharmacologic therapy optimizer smart tricuspid regurgitation acute heart failure calcium inotropic agents istaroxime lusitropic agents Na+/K+-ATPase NKA PST2744 SERCA2a biomarkers cardiac ultrasound computer tomography therapeutic interventions preventive strategies amyloidosis heart transplant ABO subtype rejection cardiogenic shock cardiac transplantation mechanical circulatory support mitral regurgitation atrial functional mitral regurgitation atrial functional tricuspid regurgitation transcatheter tricuspid valve intervention atrial fibrillation bleeding direct oral anticoagulant heart transplantation oral anticoagulant stroke vitamin K antagonist n/a thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine New Advances in Pharmacologic and Non-pharmacologic Therapy in Heart Failure and Heart Transplant |
| title | New Advances in Pharmacologic and Non-pharmacologic Therapy in Heart Failure and Heart Transplant |
| title_full | New Advances in Pharmacologic and Non-pharmacologic Therapy in Heart Failure and Heart Transplant |
| title_fullStr | New Advances in Pharmacologic and Non-pharmacologic Therapy in Heart Failure and Heart Transplant |
| title_full_unstemmed | New Advances in Pharmacologic and Non-pharmacologic Therapy in Heart Failure and Heart Transplant |
| title_short | New Advances in Pharmacologic and Non-pharmacologic Therapy in Heart Failure and Heart Transplant |
| title_sort | new advances in pharmacologic and non pharmacologic therapy in heart failure and heart transplant |
| topic | heart failure ejection fraction network meta-analysis SGLT2-inhibitors vericiguat omecamtiv mecarbil HFpEF greater splanchnic nerve ablation chronic kidney disease estimated glomerular filtration rate sodium glucose linked transporters 2 inhibitors treatment angiotensin receptor blocker neprilysin inhibitors heart failure with reduced ejection fraction cardiorenal syndrome angiotensin receptor–neprilysin inhibitors reverse cardiac remodeling renal resistance index levosimendan disease modifier drugs advanced heart failure heart failure reduced ejection fraction autonomic dysregulation respiratory disturbances novel devices cardiac contractility modulation global longitudinal strain myocardial mechano-energetics efficiency dapsone transplant G6PD anemia inodilators pharmacologic therapy optimizer smart tricuspid regurgitation acute heart failure calcium inotropic agents istaroxime lusitropic agents Na+/K+-ATPase NKA PST2744 SERCA2a biomarkers cardiac ultrasound computer tomography therapeutic interventions preventive strategies amyloidosis heart transplant ABO subtype rejection cardiogenic shock cardiac transplantation mechanical circulatory support mitral regurgitation atrial functional mitral regurgitation atrial functional tricuspid regurgitation transcatheter tricuspid valve intervention atrial fibrillation bleeding direct oral anticoagulant heart transplantation oral anticoagulant stroke vitamin K antagonist n/a thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine |
| topic_facet | heart failure ejection fraction network meta-analysis SGLT2-inhibitors vericiguat omecamtiv mecarbil HFpEF greater splanchnic nerve ablation chronic kidney disease estimated glomerular filtration rate sodium glucose linked transporters 2 inhibitors treatment angiotensin receptor blocker neprilysin inhibitors heart failure with reduced ejection fraction cardiorenal syndrome angiotensin receptor–neprilysin inhibitors reverse cardiac remodeling renal resistance index levosimendan disease modifier drugs advanced heart failure heart failure reduced ejection fraction autonomic dysregulation respiratory disturbances novel devices cardiac contractility modulation global longitudinal strain myocardial mechano-energetics efficiency dapsone transplant G6PD anemia inodilators pharmacologic therapy optimizer smart tricuspid regurgitation acute heart failure calcium inotropic agents istaroxime lusitropic agents Na+/K+-ATPase NKA PST2744 SERCA2a biomarkers cardiac ultrasound computer tomography therapeutic interventions preventive strategies amyloidosis heart transplant ABO subtype rejection cardiogenic shock cardiac transplantation mechanical circulatory support mitral regurgitation atrial functional mitral regurgitation atrial functional tricuspid regurgitation transcatheter tricuspid valve intervention atrial fibrillation bleeding direct oral anticoagulant heart transplantation oral anticoagulant stroke vitamin K antagonist n/a thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine |
| url | ONIX_20240704_9783725810192_88 |